Roy Maggie, Cardoso Cécile, Dorieux Olène, Malgorn Carole, Epelbaum Stéphane, Petit Fanny, Kraska Audrey, Brouillet Emmanuel, Delatour Benoît, Perret Martine, Aujard Fabienne, Dhenain Marc
CEA, DSV, I2BM, MIRCen, URA CEA CNRS 2210, Fontenay aux Roses, France; CNRS, URA 2210, Fontenay aux Roses, France; Research Center on Aging, Université de Sherbrooke, Sherbrooke, Quebec, Canada.
CEA, DSV, I2BM, MIRCen, URA CEA CNRS 2210, Fontenay aux Roses, France; CNRS, URA 2210, Fontenay aux Roses, France.
Neurobiol Aging. 2015 Jan;36(1):149-56. doi: 10.1016/j.neurobiolaging.2014.07.017. Epub 2014 Jul 18.
Alzheimer's disease (AD) is the most common age-related neurodegenerative disorder. Amyloid-β peptide (Aβ) deposition in the brain is one of its hallmarks, and the measure of plasma Aβ is considered to be a biomarker for anti-amyloid drug efficacy in animal models of AD. However, age-associated plasmatic Aβ modulation in animal models is practically never addressed in the literature. Mouse lemur primates are used as a model of normal and AD-like cerebral aging. Here, we studied the effect of age on plasmatic Aβ in 58 mouse lemurs aged from 1 to 10 years. A subset of animals presented high plasmatic Aβ, and the proportion of animals with high plasmatic Aβ was higher in aged animals as compared with young ones. Histologic evaluation of the brain of some of these animals was carried out to assess extracellular and intracellular amyloid load. In aged lemurs, plasmatic Aβ was negatively correlated with the density of neurons accumulating deposits of Aβ.
阿尔茨海默病(AD)是最常见的与年龄相关的神经退行性疾病。大脑中β淀粉样肽(Aβ)沉积是其特征之一,血浆Aβ的检测被认为是AD动物模型中抗淀粉样蛋白药物疗效的生物标志物。然而,文献中几乎从未涉及动物模型中与年龄相关的血浆Aβ调节。小鼠狐猴灵长类动物被用作正常和类AD脑老化的模型。在此,我们研究了年龄对58只年龄在1至10岁的小鼠狐猴血浆Aβ的影响。一部分动物血浆Aβ水平较高,与年轻动物相比,老年动物中血浆Aβ水平高的动物比例更高。对其中一些动物的大脑进行了组织学评估,以评估细胞外和细胞内淀粉样蛋白负荷。在老年狐猴中,血浆Aβ与积累Aβ沉积物的神经元密度呈负相关。